Citations

Mayo Clinic

Showing 10 of 108572 citations.

Abstract 45: Poor Prediction of Stroke Mimics Using Validated Stroke Mimic Scales in a Large Academic Telestroke Network
Chhabra, Nikita, English, Stephen , Butterfield, Richard , Hanus, Abigail, Basharath, Rida, Miller, Monet, Zhang, Nan, Demaerschalk, Bart M.

Stroke | February 1, 2024 | Volume: 55 | Issue: Suppl_1 | Pages: No page available

10.1161/str.55.suppl_1.45 Get It

Introduction: Telestroke enables timely and remote evaluation of patients with acute stroke syndromes. However, stroke mimics represent more than 30% of this population. Given the resources required for management of suspected acute ischemic stroke, several scales have been developed to help identify stroke mimics. Our objective was to externally validate four mimic scales (Khan Score [KS], TeleStroke Mimic Score [TS], simplified FABS [sFABS], and FABS) in a large, academic telestroke network. Methods: This is a retrospective, IRB exempt study of all patients who presented with suspected acute stroke syndromes and underwent video evaluation between 2019-2020 at a large academic telestroke network. Detailed chart review was conducted to extract both the variables needed to apply the mimic scales the final diagnosis confirmed by final imaging and discharge diagnosis (cerebral ischemic vs stroke mimic). Overall score performance was assessed by calculating area under curve (AUC). Youden cutpoint was established for each scale and used to calculate sensitivity, specificity, negative predictive value (NPV), positive predictive value (PPV), and accuracy. Results: A total of 1043 patients were included in the final analysis. Final diagnosis of cerebral ischemia was made in 662/1043 patients (63.5%) and stroke mimic was diagnosed in 381/1043 patients (36.5%). To predict stroke mimic, TS had the highest AUC (68.3) and PPV (73%); KS had the highest accuracy (68.6%), sensitivity (86.6%) and NPV (61.5%); and FABS had the highest specificity (54.8%) (Table 1). Conclusions: While each scale offers unique strengths, none was able to identify stroke mimics effectively enough to confidently apply in clinical practice. There remains need for significant clinical judgment to determine the likelihood of stroke mimic at presentation.
Abstract 153: First Pass Effect in Mechanical Thrombectomy for Anterior Circulation Acute Ischemic Stroke is Modified by Procedure Time: Proposal of a New Measure for Thrombectomy Procedures
Renedo, Daniela , Maier, Ilko , Kasab, Sami Al , Kim, Joon‐Tae , Quintero, Stacey C, Rai, Ansaar , Starke, Robert M. , Psychogios, Marios, Grossberg, Jonathan A , Tanweer, Omar , Polifka, Adam , Park, Min S. , Brinjikji, Waleed , Moss, Mark, Dumont, Travis M., Williamson, Richard A., Kan, Peter , Spiotta, Alejandro M , Havenon, Adam H de, Koo, Andrew B. , Reeves, Benjamin C. , Jabbour, Pascal , Psychogios, Marios‐Nikos , Shaban, Amir , Arthur, Adam Stephen , Yoshimura, Shinichi , Cuellar, Hugo , Alawieh, Ali , Romano, Daniele, Mascitelli, Justin R , Fragata, Isabel , Osbun, Joshua W , Crosa, Roberto , Levitt, Michael R. , Williamson, Richard, Navía, Pedro , Sheth, Kevin N. , Havenon, Adam de , Matouk, Charles

Stroke | February 1, 2024 | Volume: 55 | Issue: Suppl_1 | Pages: No page available

10.1161/str.55.suppl_1.153 Get It

Objective: To determine whether first pass effect (FPE) after mechanical thrombectomy (MT) for anterior circulation large vessel occlusion acute ischemic stroke (LVO-AIS) is modified by procedural time (PT). Methods: The Stroke Thrombectomy and Aneurysm Registry (STAR), a multi-center international dataset, was retrospectively analyzed for anterior circulation LVO-AIS treated by MT who achieved excellent reperfusion (TICI 2c/3). The primary outcome was good functional outcome as defined by a 90-day modified Rankin Scale (mRS) 0-2. The primary study exposure was first pass success (FPS, 1 pass vs ≥2 passes) and the secondary exposure was PT. Logistic regression models were fit-adjusted and marginal effects used to assess the interaction of PT (≤30 vs >30 minutes) and FPS, adjusting for potential confounders including time from last known well to start of MT. Results: A total of 1,310 patients had excellent reperfusion. These patients were divided into two cohorts based on PT: ≤30 minutes (777 patients, 59.3%) and > 30 minutes (533 patients, 40.7%). Good functional outcome was observed in 658 patients (50.2%). The interaction term between FPS and PT was significant (p=0.018). Individuals with FPS in ≤30 minutes had 11.5% higher adjusted predicted probability of good outcome compared with those who required ≥2 passes (58.2% vs. 46.7%, p=0.001). However, there was no significant difference in the adjusted predicted probability of good outcome based on FPS in individuals with PT >30 minutes (p=0.763). This relationship appeared identical in models with PT treated as a continuous variable. Conclusion: In a large, real-world, multi-national dataset, we find that FPE is importantly modified by PT. The added clinical benefit of FPE is lost in longer procedures (>30 minutes). These data argue for a new metric for MT procedures, namely, FPE 30 , that better represents the ideal of fast, complete reperfusion with a single pass of a thrombectomy device.
Risk Factors for Ovarian Cancer by BRCA Status: A Collaborative Case-Only Analysis
Gersekowski, Kate , Na, Renhua , Alsop, Kathryn , Delahunty, Rachel , Goode, Ellen L. , Cunningham, Julie M. , Winham, Stacey J. , Pharoah, Paul D.P. , Song, Honglin , Webb, Penelope M. , Winham, Stacey J , Webb, Penelope M , Pharoah, Paul D P , Alsop, Kathryn

Cancer Epidemiology, Biomarkers & Prevention | February 1, 2024 | Volume: 33 | Issue: 4 | Pages: 586-592

10.1158/1055-9965.epi-23-0984 | PMID 38300121 Get It

Abstract Background: Women with an inherited pathogenic variant in BRCA1 or BRCA2 have a greatly increased risk of developing ovarian cancer, but the importance of behavioral factors is less clear. We used a case-only design to compare the magnitude of associations with established reproductive, hormonal, and lifestyle risk factors between BRCA mutation carriers and noncarriers. Methods: We pooled data from five studies from the Ovarian Cancer Association Consortium including 637 BRCA carriers and 4,289 noncarriers. Covariate-adjusted generalized linear mixed models were used to estimate interaction risk ratios (IRR) and 95% confidence intervals (CI), with BRCA (carrier vs. noncarrier) as the response variable. Results: IRRs were above 1.0 for known protective factors including ever being pregnant (IRR = 1.29, 95% CI; 1.00–1.67) and ever using the oral contraceptive pill (1.30, 95% CI; 1.07–1.60), suggesting the protective effects of these factors may be reduced in carriers compared with noncarriers. Conversely, the IRRs for risk factors including endometriosis and menopausal hormone therapy were below 1.0, suggesting weaker positive associations among BRCA carriers. In contrast, associations with lifestyle factors including smoking, physical inactivity, body mass index, and aspirin use did not appear to differ by BRCA status. Conclusions: Our results suggest that associations with hormonal and reproductive factors are generally weaker for those with a pathogenic BRCA variant than those without, while associations with modifiable lifestyle factors are similar for carriers and noncarriers. Impact: Advice to maintain a healthy weight, be physically active, and refrain from smoking will therefore benefit BRCA carriers as well as noncarriers.
“God is going to help me get through this”: spirituality perspectives from Hispanic adolescent and young adult cancer survivors.
Bennett, Claire , Doyon, Katherine , Hendricks‐Ferguson, Verna L. , Bennett, C Robert

No container title available | February 1, 2024 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-3904187/v1 Get It

Abstract Purpose: Describe spirituality’s role in a sample of Hispanic adolescent and young adult (AYA) cancer survivors. Methods: This convergent parallel mixed-methods study aimed to explore participants’ lived experiences with hope during cancer treatments and cancer survivorship. A purposive sample of Hispanic AYAs aged 18-39 years who completed cancer treatments 2-5 years ago were virtually recruited for participation. First, participants completed surveys about hope, demoralization, depression and anxiety, and health related quality of life. Second, participants completed virtual semi-structured interviews about their experiences with hope during cancer treatments and cancer survivorship and prepared narratives about their experiences. Thematic analyses were iteratively performed across the data set to identify final themes. Results: Ten Hispanic AYA cancer survivors aged 22-36 years old participated in this pilot study. Seven participants (70%) were female, and three participants (30%) were male. Six participants (60%) experienced non-hematologic malignancies, and four participants (40%) experienced hematologic malignancies. Eight participants (80%) preferred to participate using Spanish, while two (20%) preferred to participate using English. The theme Spirituality, and subthemes Living by Faith, God as a Resource, and Spiritual Gratitude were identified as concepts participants linked to their conceptualization of hope during cancer treatment and survivorship. Conclusions: Hope and spirituality may be conceptually linked to coping behaviors among Hispanic AYA cancer survivors. Hope through faith may be a learned spiritual value in Hispanic AYAs and might play a role in their spiritual and cognitive development. Further research is needed to explore the potentially protective value of hope and spirituality for the Hispanic AYA population.
Endoscopic Endonasal Transcavernous Hemipituitary Transposition for Resection of Invasive Prolactinoma: 2-Dimensional Operative Video
Caicedo, Diana C. Alvarez , Donaldson, Angela M. , Samson, Susan L. , Chaichana, Kaisorn L. , Almeida, João Paulo , Alvarez Caicedo, Diana C, Almeida, Joao Paulo

Operative Neurosurgery | February 1, 2024 | Volume: 27 | Issue: 1 | Pages: 129-130

10.1227/ons.0000000000001075 | PMID 38299803 Get It

The relationship between performance validity testing, external incentives, and cognitive functioning in long COVID
Whiteside, Douglas M. , Basso, Michael R. , Shen, Chen , Fry, Laura, Naini, Savana M. , Waldron, Eric J. , Holker, Erin , Porter, Jim, Eskridge, Courtney, Logemann, Allison, Minor, Greta , Whiteside, Douglas , Porter, Jim

Journal of Clinical and Experimental Neuropsychology | February 1, 2024 | Volume: 46 | Issue: 1 | Pages: 6-15

10.1080/13803395.2024.2312625 | PMID 38299800 Get It

Awake brain mapping paradigms for nondominant hemisphere gliomas
Sabsevitz, David S. , Campo, Isabel Martin del , Gillespie, Conor S. , Middlebrooks, Erik H. , Chaichana, Kaisorn L. , Lee, Keng Siang , Sánchez-Garavito, Jesús E. , Quiñones‐Hinojosa, Alfredo , Ekert, Justyna O. , Martin Del Campo, Isabel, Middlebrooks, Erik H , Goyal, Anshit

Neurosurgical Focus | February 1, 2024 | Volume: 56 | Issue: 2 | Pages: E7

10.3171/2023.11.focus23610 | PMID 38301243 Get It

OBJECTIVE Traditionally, resection of nondominant hemisphere brain tumors was performed under general anesthesia. An improved understanding of right-lateralized neural networks has led to a paradigm shift in recent decades, where the right or nondominant hemisphere is no longer perceived as "functionally silent." There is an increasing interest in awake brain mapping for nondominant hemisphere resections. The objective of this study was to perform a comprehensive review of the existing brain mapping paradigms for patients with nondominant hemisphere gliomas undergoing awake craniotomies. METHODS In accordance with PRISMA guidelines, systematic searches of the Medline, Embase, and American Psychological Association PsycInfo databases were undertaken from database inception to July 1, 2023. Studies providing a description of the intraoperative mapping paradigm used to assess cognition during an awake craniotomy for resection of a nondominant hemisphere glioma were included. RESULTS The search yielded 1084 potentially eligible articles. Thirty-nine unique studies reporting on 788 patients were included in the systematic review. The most frequently tested cognitive domains in patients with nondominant hemisphere tumors were spatial attention/neglect (17/39 studies, 43.6%), speech-motor/language (17/39 studies, 43.6%), and social cognition (9/39 studies, 23.1%). Within the frontal lobe, the highest number of positive mapping sites was identified for speech-motor/language, spatial attention/neglect, dual tasking assessing motor and language function, working memory, and social cognition. Within the parietal lobe, eloquence was most frequently found upon testing spatial attention/neglect, speech-motor/language, and calculation. Within the temporal lobe, the assessment of spatial attention/neglect yielded the highest number of positive mapping sites. CONCLUSIONS Cognitive testing in the nondominant hemisphere is predominantly focused on evaluating two domains: spatial attention/neglect and the motor aspects of speech/language. Multidisciplinary teams involved in awake brain mapping should consider testing an extended range of functions to minimize the risk of postoperative deficits and provide valuable information about anatomo-functional organization of cognitive networks.
Abstract A037: Investigating the role of the somatic DDX41 variant in the context of DDX41 hereditary myeloid malignancy syndromes (HMMS)
Marando, Ludovica , Kusne, Yael , Morris, Audrey, Mangaonkar, Abhishek A. , Finke, Christy M. , Crawley, Carles, Foran, James M. , Al‐Kali, Aref , Gangat, Naseema , He, Rong , Viswanatha, David S., Basheer, Faisal, Litzow, Mark R. , Patnaik, Mrinal M. , Badar, Talha , Lasho, Terra L. , King, Andrew Peter , Alkhateeb, Hassan B. , Wong, Chi, Ferrer, Alejandro , Vassiliou, George S.

Cancer Research | February 1, 2024 | Volume: 84 | Issue: 3_Supplement_2 | Pages: A037-A037

10.1158/1538-7445.canevol23-a037 Get It

Abstract Heterozygous germline variants in DDX41 are identified in ~5% of patients with Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia (AML). Recognition of the hereditary nature of such cancers and a better understanding of the factors that affect progression to malignancy has deep implications for health surveillance of patients and relatives that share a pathogenic DNA variant. DDX41 has a role in ribosome biogenesis and in opposing R-loop accumulation at promoters, but the mechanisms through which DDX41 loss drives cancer development are poorly understood. In a collaboration between Cambridge, UK and Mayo Clinic, USA we identified 85 patients with germline DDX41 variants [73/85 with germline pathogenic variants (GPV) and 12 with variants of uncertain significance (VUS)]. The majority were identified through targeted myeloid NGS upon presentation with AML (30/85) or MDS (44/85). Average age at diagnosis was 65 (35-93) with male predominance (57/85). The most common GPV was the NM_016222.4(DDX41):c.415_418dup; p.D140Gfs*2 (15/85). The majority (53.4% 39/73), also acquired a somatic variants in the other DDX41 allele (referred to as GPV+Som). The most common somatic variant (82% 32/39) was the R525H, a variant predicted to reduce the ATPase function of the helicase domain. We hypothesise that the markedly reduced DDX41 activity in cells with biallelic variants, is a key cause of progression to overt malignancy. In our cohort, we observed that somatic variants occurred at a similar frequency in association with start loss, truncating, splice, in-frame deletion, and missense GPV. However, whereas MDS was the predominant diagnosis within GPV (67.6% 23/34, AML 26.4% 9/34), AML was the most frequent diagnosis within GPV+Som (AML 51%.2 20/39, MDS 38.4% 15/39). Overall, there was a significantly higher likelihood of AML in the presence of a somatic variant (p<0.05), suggesting that there might be a dosage effect on the phenotype. This pattern was observed across all the GPV, with the exception of missense, suggesting that many might be benign polymorphysms. In addition, although somatic variants are typically subclonal (overall mean variant allele fraction VAF=9.87%, 3-27.8%), we observed a higher somatic VAF in AML over MDS cases (12.4% vs 7.7% respectively p<0.05). A lower bone marrow cellularity was also characteristic of GPV+Som vs GPV alone (mean observed/expected cellularity for age 0.9 vs 1.32 respectively p<0.05). In two cases, serial bone marrow morphology and NGS data were available, and we observed marked reduction in bone marrow cellularity upon acquisition of the R525H clone. The mechanisms of AML evolution appear different in DDX41 HMMS compared to sporadic cases. Interestingly, over half of our patients (21/34 GPV and 23/39 GPV+Som) did not exhibit additional somatic drivers. Our work suggests that acquisition of a somatic variant is a critical event in disease progression. Furthermore, the near universally subclonal nature of somatic variants suggest that they may affect disease phenotype through non-cell autonomous mechanisms. Citation Format: Ludovica Marando, Talha Badar, Yael Kusne, Audrey Morris, Terra Lasho, Abhishek Mangaonkar, Christy Finke, Carles Crawley, James M. Foran, Aref Al-Kali, Andrew King, Hassan Alkhateeb, Naseema Gangat, Chi Wong, Rong He, David Viswanatha, Faisal Basheer, Mark Litzow, Alejandro Ferrer, George Vassiliou, Mrinal Patnaik. Investigating the role of the somatic DDX41 variant in the context of DDX41 hereditary myeloid malignancy syndromes (HMMS) [abstract]. In: Proceedings of the AACR Special Conference in Cancer Research: Translating Cancer Evolution and Data Science: The Next Frontier; 2023 Dec 3-6; Boston, Massachusetts. Philadelphia (PA): AACR; Cancer Res 2024;84(3 Suppl_2):Abstract nr A037.
Abstract B026: Dissecting the pancreatic cancer microenvironment using landscape ecology
Siddiqui, Zafar, Meroueh, Chady , Singh, Ritambhara , Fernández-Zapico, Martín E. , Siddiqui, Zafar , Meroueh, Chady , Toruner, Merih Deniz , Cisneros, Luis , Maley, Carlo C. , Carr, Ryan M

Cancer Research | February 1, 2024 | Volume: 84 | Issue: 3_Supplement_2 | Pages: B026-B026

10.1158/1538-7445.canevol23-b026 Get It

Abstract Pancreatic ductal adenocarcinoma (PDAC) is predicted to be the second cause of cancer death in the US by 2040. Five-year overall survival is only ~12% despite decades of research. The mainstay of treatment remains chemotherapy in the absence of highly recurrent, therapeutically actionable, genetic targets. For the minority of patients (~15-20%) who are candidates for curative-intent surgical resection, six months of intensive neoadjuvant chemotherapy with/without chemoradiation has become standard-of-care. However, despite evidence of radiographic, metabolic, and biochemical responses, significant viable residual disease on pathologic analysis is almost universally observed with approximately 40-60% risk of disease recurrence. Thus, there is a critical need to better understand why PDAC remains recalcitrant to current therapeutic modalities. Pathologic evaluation of PDAC reveals a complex microenvironment consisting of neoplastic cells dynamically interacting with both “normal” cellular (e.g. mesenchymal, immune) and non-cellular (e.g. collagen) stromal elements. While biologically important, experimental models and small-scale efforts to dissect the PDAC ecosystem are limited by focus on individual tumor compartments and generation of conflicting results. Consequently, there is a need for a more comprehensive understanding of the structure and dynamics of the PDAC TME through the theoretical lens of evolutionary ecology. Current therapies are not focused on the PDAC ecosystem. We hypothesize that cell-cell interactions of PDAC cells with its local niche are important for conferring treatment resistance. Thus, better understanding of said interactions could yield novel ecologically-informed therapies. Consequently, we developed a digital pathology library of approximately 1000 PDAC resection cases (whole-slide H&E images) performed at Mayo Clinic between 2013-2021. Approximately 400 cases are treatment naive while about 600 were treated with neoadjuvant therapy. While some qualitative features of pathologic analysis have prognostic value (e.g., pathologic treatment response, presence of perineural or lymphovascular invasion, extent of desmoplasia), we aim to identify prognostic spatial relationships using tools from landscape ecology. We utilized the HoVer-Net model for nuclei segmentation and classification and spatial statistics methods and landscape fragmentation analysis to understand the spatial organization within the PDAC tumor ecology. With these methodologies, we can assess the spatial context of cell interactions, habitat/niche/microenvironment formation, ecological relationships between cell populations, and the different tissue components. The different spatial statistics/metrics are used to quantify levels of immune cell infiltration, mixing, as well as the complexity and diversity of microenvironment phenotypes leading to high levels of tumor heterogeneity. Such measurements can help predict the likelihood of a PDAC tumor adaptive potential that could lead to fast evolutionary responses to therapy, progression, and poor prognosis. Citation Format: Merih D. Toruner, Luis Cisneros, Zafar Siddiqui, Chady Meroueh, Ritambhara Singh, Carlo Maley, Martin E. Fernandez-Zapico, Ryan M. Carr. Dissecting the pancreatic cancer microenvironment using landscape ecology [abstract]. In: Proceedings of the AACR Special Conference in Cancer Research: Translating Cancer Evolution and Data Science: The Next Frontier; 2023 Dec 3-6; Boston, Massachusetts. Philadelphia (PA): AACR; Cancer Res 2024;84(3 Suppl_2):Abstract nr B026.
Abstract IA003: Composing each patient's equation: Deciphering brain tumor dynamics and evolution by integrating multi-regional image-localized biopsies
Swanson, Kristin R. , Swanson, Kristin R

Cancer Research | February 1, 2024 | Volume: 84 | Issue: 3_Supplement_2 | Pages: IA003-IA003

10.1158/1538-7445.canevol23-ia003 Get It

Abstract Glioblastoma is a uniquely challenging and aggressive cancer that is practically considered uniformly fatal. This aggressiveness is driven by heterogeneity between and within patients and the diffuse invasion of tumor cells deep into the normal appearing brain tissue surrounding the frank tumor abnormality. We use our unique collection of 1000+ image-localized biopsies across nearly 200 patients to detect sex-distinct patterns of mapping between regional imaging features and underlying regional tumor biology. Specifically, we build mathematical models that fuse locoregional changes on MRI to underlying changes in tumor biology. We apply the resultant spatio-temporal models to serial imaging of patients receiving a variety of standard of care and novel therapeutics to track tumor dynamics under said therapies. This allows us unprecedent insight into the dynamics of each patients tumor under therapy. This includes detecting clonal loss through targeted therapies as well as shifts in the tumor ecosystem under immunotherapies. In this presentation, I will demonstrate how these methods can be brought together to help us detect, decipher and predict tumor dynamics and evolution in patients. Specifically, I will demonstrate the value of these novel combined resources in predicting response to treatment for EGFR-targeted therapies in 3 clinical trials and differentiating response to novel dendritic cells vaccines and CAR T-cell therapies in 2 additional clinical trials. Taken together, these complimentary approaches provide a platform to incorporate inter- and intra- tumoral heterogeneity into accurate predictive models that advance evolutionary- and ecologically-adaptive precision oncology for glioblastoma patients. Citation Format: Kristin R. Swanson. Composing each patient's equation: Deciphering brain tumor dynamics and evolution by integrating multi-regional image-localized biopsies [abstract]. In: Proceedings of the AACR Special Conference in Cancer Research: Translating Cancer Evolution and Data Science: The Next Frontier; 2023 Dec 3-6; Boston, Massachusetts. Philadelphia (PA): AACR; Cancer Res 2024;84(3 Suppl_2):Abstract nr IA003.